Literature DB >> 30551852

Novel imaging techniques in staging oesophageal cancer.

Kieran Foley1, John Findlay2, Vicky Goh3.   

Abstract

The survival of oesophageal cancer is poor as most patients present with advanced disease. Radiological staging of oesophageal cancer is complex but is fundamental to clinical management. Accurate staging investigations are vitally important to guide treatment decisions and optimise patient outcomes. A combination of baseline computed tomography (CT), endoscopic ultrasound (EUS) and positron emission tomography (PET) are currently used for initial treatment decisions. The potential value of these imaging modalities to re-stage disease, monitor response and alter treatment is currently being investigated. This review presents an essential update on the accuracy of oesophageal cancer staging investigations, their use in re-staging after neo-adjuvant therapy and introduces evolving imaging techniques, including novel biomarkers that have clinical potential in oesophageal cancer. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography; Endoscopic ultrasound; Magnetic resonance imaging; Oesophageal cancer; Positron-emission tomography; Prognosis; Response; Staging; TNM

Mesh:

Year:  2018        PMID: 30551852     DOI: 10.1016/j.bpg.2018.11.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  7 in total

1.  Endoscopic Ultrasound Stagingof Esophageal Cancer.

Authors:  Shyam Thakkar; Vivek Kaul
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-01

2.  A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.

Authors:  Xiaohui Chen; Yilin Yu; Haishan Wu; Jianjian Qiu; Dongmei Ke; Yahua Wu; Mingqiang Lin; Tianxiu Liu; Qunhao Zheng; Hongying Zheng; Jun Yang; Zhiping Wang; Hui Li; Lingyun Liu; Qiwei Yao; Jiancheng Li; Wenfang Cheng
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

3.  Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging.

Authors:  Hongyao Xu; Shengxi Wu; Hesan Luo; Chuyun Chen; Lianxing Lin; Hecheng Huang; Renliang Xue
Journal:  Cancer Med       Date:  2019-09-04       Impact factor: 4.452

4.  Value of 18F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With 18F-FDG PET/CT, MRI, and Contrast-Enhanced CT.

Authors:  Fei Wang; Rui Guo; Yan Zhang; Boqi Yu; Xiangxi Meng; Hanjing Kong; Yang Yang; Zhi Yang; Nan Li
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

5.  Comparison of gross target volumes based on four-dimensional CT, positron emission tomography-computed tomography, and magnetic resonance imaging in thoracic esophageal cancer.

Authors:  Huimin Li; Fengxiang Li; Jianbin Li; Youzhe Zhu; Yingjie Zhang; Yanluan Guo; Min Xu; Qian Shao; Xijun Liu
Journal:  Cancer Med       Date:  2020-06-08       Impact factor: 4.452

6.  Detecting lymph node metastasis of esophageal cancer on dual-energy computed tomography.

Authors:  Xuyang Sun; Tetsu Niwa; Soji Ozawa; Jun Endo; Jun Hashimoto
Journal:  Acta Radiol       Date:  2020-12-16       Impact factor: 1.701

7.  Heterogeneity of T3 stage esophageal squamous cell carcinoma in different parts based on enhanced CT radiomics.

Authors:  Xiao-Feng Li; Qiang Wang; Shao-Feng Duan; Biao Yao; Cai-Yun Liu
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.